Notably, four of these proteins (i.e., EGFR, IGF-IR, PDGFRβ and Axl) also showed the highest increase in phosphorylation in cancer tissue samples after denosumab treatment compared to untreated samples (Figure 2A). The gene discussed is AXL; the disease is cancer.